• Latest News Releases

    SAN FRANCISCO – New results from a landmark clinical trial have confirmed the long-term effectiveness and safety of the drugs Avastin and Lucentis for treating age-related macular degeneration, a major cause of blindness. The study found that half of eyes treated with either drug after five years maintained vision typically considered good enough to drive and read. The researchers called the results “remarkable” given that before these drugs were available the majority of people with the condition would have gone legally blind. The study is being published online today in Ophthalmology, the journal of the American Academy of Ophthalmology.
    WASHINGTON - The American Academy of Ophthalmology is supporting a proposal introduced recently in Congress to protect safety for millions of patients who require contact lens prescriptions. The Academy believes that the Contact Lens Consumer Health Act (S. 2777) is a much-needed update to existing prescribing laws that would make significant strides in ensuring patient safety.
    SAN FRANCISCO – The American Academy of Ophthalmology is encouraging everyone to take charge of their eye health and preserve their sight by following some simple tips as part of Healthy Vision Month in May.
    WASHINGTON ― The American Academy of Ophthalmology is honoring five Members of Congress for their outstanding legislative efforts to advance the quality of eye care available in the United States. The Academy is presenting its 2016 Visionary Awards to Sen. Bill Cassidy, M.D., R-La., and Reps. Phil Roe, M.D., R-Tenn., Paul Tonko, D-N.Y., Raul Ruiz, M.D., D-Calif., and Ami Bera, M.D., D-Calif.